Tema ETFs’s AnaptysBio ANAB Stock Holding History
Bought
Maintained
Sold
Other funds holding ANAB
Tema ETFs's ANAB Position: Q3 2026 in Review
Tema ETFs increased its AnaptysBio (ANAB) stake by 6.9% in Q3 2026, buying an estimated $121K and bringing the position to 33,414 shares worth $1.68M. The position accounts for 0.06% of the portfolio, ranked #211.
Tema ETFs first reported a position in ANAB in Q2 2025 and has held it in 6 quarters since. The position peaked at $2.11M in Q2 2026. 14 funds tracked by Wall St. Rank hold ANAB as of Q3 2026.
- Tema ETFs held 33,414 shares of AnaptysBio worth $1.68M as of Q3 2026.
- Tema ETFs bought 2,144 AnaptysBio shares in Q3 2026, an estimated $121K.
- AnaptysBio made up 0.06% of Tema ETFs's portfolio in Q3 2026, its #211 holding.
- Tema ETFs first reported a position in AnaptysBio in Q2 2025 and has held it in 6 quarters since.
- Tema ETFs's AnaptysBio position peaked at $2.11M in Q2 2026.
- 14 funds tracked by Wall St. Rank held AnaptysBio as of Q3 2026.
Based on Tema ETFs's 13F filing for Q3 2026, filed 16 Oct 2026.